ResMed Inc. (RSMDF)

Market Cap	36.04B
Revenue (ttm)	5.26B
Net Income (ttm)	1.44B
Shares Out	n/a
EPS (ttm)	9.77
PE Ratio	25.06
Forward PE	22.11
Dividend	n/a
Ex-Dividend Date	n/a

Volume	39
Average Volume	40,395
Open	24.59
Previous Close	26.16
Day's Range	24.59 - 29.82
52-Week Range	11.91 - 30.00
Beta	n/a
RSI	58.43
Earnings Date	Oct 30, 2025

About ResMed

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1989
• Employees: 10,600
• Stock Exchange: OTCMKTS
• Ticker Symbol: RSMDF

Financial Performance

In 2025, ResMed's revenue was $5.15 billion, an increase of 9.84% compared to the previous year's $4.69 billion. Earnings were $1.40 billion, an increase of 37.20%.